{"id":"https://openalex.org/W2804727484","doi":"https://doi.org/10.1177/2040620718774268","title":"Acute myeloid leukemia chimeric antigen receptor T-cell immunotherapy: how far up the road have we traveled?","display_name":"Acute myeloid leukemia chimeric antigen receptor T-cell immunotherapy: how far up the road have we traveled?","alternate_titles":[],"publication_year":2018,"publication_date":"2018-05-17","ids":{"openalex":"https://openalex.org/W2804727484","doi":"https://doi.org/10.1177/2040620718774268","mag":"2804727484","pmid":"https://pubmed.ncbi.nlm.nih.gov/29899889","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5992809"},"language":"en","primary_location":{"id":"doi:10.1177/2040620718774268","doi":"https://doi.org/10.1177/2040620718774268","is_oa":true,"landing_page_url":"https://doi.org/10.1177/2040620718774268","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/2040620718774268","source":{"id":"https://openalex.org/S2765068629","display_name":"Therapeutic Advances in Hematology","issn_l":"2040-6207","issn":["2040-6207","2040-6215"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Hematology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2804727484"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://journals.sagepub.com/doi/pdf/10.1177/2040620718774268","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066964026","display_name":"Sarah Kathleen Tasian","orcid":"https://orcid.org/0000-0003-1327-1662","observed_orcids":["https://orcid.org/0000-0003-1327-1662"]},"institutions":[{"id":"https://openalex.org/I1335321130","display_name":"Children's Hospital of Philadelphia","ror":"https://ror.org/01z7r7q48","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1335321130"]},{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Sarah K Tasian","raw_affiliation_strings":["Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania and Abramson Cancer Center, 3501 Civic Center Boulevard, CTRB, 3010, Philadelphia, PA, 19104, USA","Division of Oncology and Center for Childhood Cancer Research, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"],"raw_orcid":"https://orcid.org/0000-0003-1327-1662","affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania and Abramson Cancer Center, 3501 Civic Center Boulevard, CTRB, 3010, Philadelphia, PA, 19104, USA","institution_ids":["https://openalex.org/I4390039297","https://openalex.org/I79576946"]},{"raw_affiliation_string":"Division of Oncology and Center for Childhood Cancer Research, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania","institution_ids":["https://openalex.org/I1335321130"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5066964026"],"corresponding_institution_ids":["https://openalex.org/I1335321130","https://openalex.org/I4390039297","https://openalex.org/I79576946"],"apc_list":{"value":2650,"currency":"USD","value_usd":2650},"apc_paid":null,"fwci":1.489,"has_fulltext":true,"cited_by_count":69,"citation_normalized_percentile":{"value":0.83660497,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"9","issue":"6","first_page":"135","last_page":"148"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.948199987411499,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.948199987411499,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.03629999980330467,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.8939999938011169},{"id":"https://openalex.org/keywords/relapsed-refractory-aml","display_name":"relapsed/refractory AML","score":0.953000009059906},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.8019999861717224},{"id":"https://openalex.org/keywords/on-target-off-tumor-toxicity","display_name":"on-target off-tumor toxicity","score":0.7850000262260437},{"id":"https://openalex.org/keywords/target-antigen-selection","display_name":"target antigen selection","score":0.8100000023841858},{"id":"https://openalex.org/keywords/car-t-cell-resistance","display_name":"CAR T-cell resistance","score":0.9490000009536743},{"id":"https://openalex.org/keywords/precision-medicine","display_name":"precision medicine","score":0.7419999837875366}],"concepts":[{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.8852717876434326},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8392046093940735},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.7475506067276001},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6756452918052673},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.5402142405509949},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5229238271713257},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4878509044647217},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.46270325779914856},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.45337364077568054},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4501946270465851},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.37857192754745483},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3398614525794983},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.22369951009750366}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1177/2040620718774268","doi":"https://doi.org/10.1177/2040620718774268","is_oa":true,"landing_page_url":"https://doi.org/10.1177/2040620718774268","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/2040620718774268","source":{"id":"https://openalex.org/S2765068629","display_name":"Therapeutic Advances in Hematology","issn_l":"2040-6207","issn":["2040-6207","2040-6215"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Hematology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4950949","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC5992809","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5992809","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5992809/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ther Adv Hematol","raw_type":"Text"},{"id":"pmid:29899889","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29899889","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic advances in hematology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1177/2040620718774268","doi":"https://doi.org/10.1177/2040620718774268","is_oa":true,"landing_page_url":"https://doi.org/10.1177/2040620718774268","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/2040620718774268","source":{"id":"https://openalex.org/S2765068629","display_name":"Therapeutic Advances in Hematology","issn_l":"2040-6207","issn":["2040-6207","2040-6215"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Hematology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G306920810","display_name":"PI3K Pathway Inhibition for Philadelphia-Like Acute Lymphoblastic Leukemia","funder_award_id":"K08CA184418","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306091","display_name":"American Association for Cancer Research","ror":"https://ror.org/02fnpv153"},{"id":"https://openalex.org/F4320307428","display_name":"Rally Foundation","ror":"https://ror.org/01mkym489"},{"id":"https://openalex.org/F4320308906","display_name":"St. Baldrick's Foundation","ror":"https://ror.org/03h1gea69"},{"id":"https://openalex.org/F4320311601","display_name":"Gabrielle's Angel Foundation for Cancer Research","ror":"https://ror.org/04aj0cy60"},{"id":"https://openalex.org/F4320332898","display_name":"Stand Up To Cancer","ror":"https://ror.org/01dmpb598"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2804727484.pdf","grobid_xml":"https://content.openalex.org/works/W2804727484.grobid-xml"},"referenced_works_count":98,"referenced_works":["https://openalex.org/W288116742","https://openalex.org/W1619537825","https://openalex.org/W1719275795","https://openalex.org/W1839053269","https://openalex.org/W1967995010","https://openalex.org/W1976187277","https://openalex.org/W1987633400","https://openalex.org/W1994448489","https://openalex.org/W2000273667","https://openalex.org/W2004639735","https://openalex.org/W2005600353","https://openalex.org/W2013971016","https://openalex.org/W2014751400","https://openalex.org/W2021083150","https://openalex.org/W2021663709","https://openalex.org/W2022881751","https://openalex.org/W2028069487","https://openalex.org/W2030249962","https://openalex.org/W2065406906","https://openalex.org/W2069907861","https://openalex.org/W2077057971","https://openalex.org/W2077994554","https://openalex.org/W2079846411","https://openalex.org/W2093192794","https://openalex.org/W2094945699","https://openalex.org/W2098690052","https://openalex.org/W2099570622","https://openalex.org/W2112041130","https://openalex.org/W2112850316","https://openalex.org/W2113752195","https://openalex.org/W2116858301","https://openalex.org/W2118796952","https://openalex.org/W2122465970","https://openalex.org/W2129702476","https://openalex.org/W2130338247","https://openalex.org/W2141869972","https://openalex.org/W2146862320","https://openalex.org/W2157258473","https://openalex.org/W2161364758","https://openalex.org/W2169923083","https://openalex.org/W2179454156","https://openalex.org/W2203017588","https://openalex.org/W2211296957","https://openalex.org/W2259451566","https://openalex.org/W2282600624","https://openalex.org/W2335984750","https://openalex.org/W2340435799","https://openalex.org/W2340862784","https://openalex.org/W2342423058","https://openalex.org/W2400439118","https://openalex.org/W2408097265","https://openalex.org/W2419639370","https://openalex.org/W2465973558","https://openalex.org/W2470876555","https://openalex.org/W2478380301","https://openalex.org/W2496398835","https://openalex.org/W2508697147","https://openalex.org/W2525034031","https://openalex.org/W2557368153","https://openalex.org/W2558503402","https://openalex.org/W2560105972","https://openalex.org/W2560318964","https://openalex.org/W2583070206","https://openalex.org/W2588973392","https://openalex.org/W2593086395","https://openalex.org/W2604003809","https://openalex.org/W2606654718","https://openalex.org/W2611952484","https://openalex.org/W2613026858","https://openalex.org/W2621998980","https://openalex.org/W2726931548","https://openalex.org/W2733796015","https://openalex.org/W2738658820","https://openalex.org/W2754562068","https://openalex.org/W2760997984","https://openalex.org/W2761903029","https://openalex.org/W2765972717","https://openalex.org/W2765978780","https://openalex.org/W2766375908","https://openalex.org/W2768493580","https://openalex.org/W2768799228","https://openalex.org/W2768823259","https://openalex.org/W2772481439","https://openalex.org/W2782257254","https://openalex.org/W2783779434","https://openalex.org/W2785500950","https://openalex.org/W2786931232","https://openalex.org/W2787301955","https://openalex.org/W2787621143","https://openalex.org/W2790987046","https://openalex.org/W2791898577","https://openalex.org/W2794038413","https://openalex.org/W2913271650","https://openalex.org/W2913275810","https://openalex.org/W2915887287","https://openalex.org/W2951475279","https://openalex.org/W2979737548","https://openalex.org/W2979960888"],"related_works":["https://openalex.org/W4410040336","https://openalex.org/W3107384013","https://openalex.org/W4205382255","https://openalex.org/W4394887923","https://openalex.org/W4413020667","https://openalex.org/W7165191596","https://openalex.org/W4404995922","https://openalex.org/W4205196699","https://openalex.org/W4388630429","https://openalex.org/W3028759332"],"abstract_inverted_index":{"Chemotherapy":[0],"resistance":[1,151],"and":[2,11,34,48,65,93,142],"relapse":[3],"remain":[4],"significant":[5],"sources":[6],"of":[7,20,32,50,113,120,128,133,138,144,157],"mortality":[8],"for":[9,56,154,160],"children":[10],"adults":[12,103],"with":[13,58,87,104,162],"acute":[14,33],"myeloid":[15,122],"leukemia":[16,63],"(AML).":[17],"Further":[18],"intensification":[19],"conventional":[21],"cytotoxic":[22],"chemotherapy":[23],"is":[24,68],"likely":[25],"not":[26],"feasible":[27],"due":[28],"to":[29,146],"the":[30],"severity":[31],"long-term":[35],"side":[36],"effects":[37],"upon":[38],"normal":[39,121],"tissues":[40],"commonly":[41],"induced":[42,82],"by":[43],"these":[44],"drugs.":[45],"Successful":[46],"development":[47,143],"implementation":[49,127,156],"new":[51],"precision":[52],"medicine":[53],"treatment":[54],"approaches":[55],"patients":[57,86,161],"AML,":[59],"which":[60],"may":[61,124],"improve":[62],"remission":[64],"diminish":[66],"toxicity,":[67],"thus":[69],"a":[70],"major":[71],"priority.":[72],"Tumor":[73],"antigen-redirected":[74],"chimeric":[75],"antigen":[76],"receptor":[77],"(CAR)":[78],"T-cell":[79,116,150],"immunotherapies":[80,159],"have":[81],"remarkable":[83],"responses":[84],"in":[85,102],"relapsed":[88],"or":[89],"chemorefractory":[90],"B-lymphoblastic":[91],"leukemia,":[92],"similar":[94],"strategies":[95],"are":[96,152],"now":[97],"under":[98],"early":[99],"clinical":[100],"study":[101],"relapsed/refractory":[105],"AML.":[106,164],"However,":[107],"potential":[108,148],"on":[109],"target/off":[110],"tumor":[111],"toxicity":[112,139],"AML":[114],"CAR":[115,149],"immunotherapies,":[117],"notably":[118],"aplasia":[119],"cells,":[123],"limit":[125],"broader":[126],"such":[129],"approaches.":[130],"Careful":[131],"selection":[132],"optimal":[134],"target":[135],"antigens,":[136],"consideration":[137],"mitigation":[140],"strategies,":[141],"methodologies":[145],"circumvent":[147],"essential":[153],"successful":[155],"cellular":[158],"high-risk":[163]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2804727484","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":22},{"year":2018,"cited_by_count":5}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2018-06-01T00:00:00"}
